Company page

Ibio, Inc.

Ibio, Inc. is a public company traded under the ticker IBIO in the American market. The company has a market capitalization of approximately $71 million. Ibio focuses on developing innovative biopharmaceutical products using its proprietary plant-based protein production platform.